Isto Biologics Overview

Medical ProductsCompany

Is Isto Biologics PE-backed?

Yes. Isto Biologics is owned by private equity investor Keensight Capital.

Was Isto Biologics formerly PE-backed?

Yes. Isto Biologics was formerly owned by 1 private investor.

Where is Isto Biologics headquartered?

Isto Biologics is headquartered in Hopkinton, Massachusetts.

What sector is Isto Biologics in?

Isto Biologics is a medical products company.

When was Isto Biologics founded?

Isto Biologics was founded in 2016.

Isto Biologics

Isto Biologics, Inc.

45 South Street,
Hopkinton, Massachusetts 01748
United States,
(888) 705-4786
www.istobiologics.com

Isto Biologics is an orthobiologics company providing advanced solutions for the spine and orthopedics markets. Isto Biologics offers an innovative portfolio of products, including InQu Bone Graft Extender & Substitute, Influx Trabecular Bone Graft, and CellPoint Concentrated Bone Marrow Aspirate System. Isto Biologics was founded in 2016 and is based in Hopkinton, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 1 - 1 - - - 2
Sell (0.0/yr) # - - - - - - 0
  2

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.